Dicerna Pharmaceuticals Alternatives & Competitors
12 companies similar to Dicerna Pharmaceuticals — Pioneering breakthroughs in genetic disorders and liver diseases using RNA inter...
Companies similar to Dicerna Pharmaceuticals
Genecure
Innovative gene transfer technology aiming to combat genetic disorders, infectious disease...
Benitec Biopharma Inc.
Silencing genes for life
Hayward, United States
Dynacure
Dynacure develops new treatments for orphan disorders, focusing on CNM through Dyn101 prog...
Illkirch-graffenstaden, F...
Acceleron Pharma
Accelerating drug discovery to transform patients' lives
Cambridge, United States
Track all Dicerna Pharmaceuticals competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Versantis
Multiorgan support for rare pediatric and acute liver diseases
Zurich, Switzerland
ProQR Therapeutics
Advancing our proprietary Axiomer™ RNA-editing platform technology
Leiden, The Netherlands
HemoShear Therapeutics
Developing new treatments for rare metabolic disorders
Charlottesville, United S...
Moderna
Our mission is to deliver the greatest possible impact to people through mRNA medicines.
Cambridge, United States
Revive Therapeutics Ltd. CSE: RVV | USA: RVVTF
Focused on the research and development of therapeutics for infectious diseases and rare d...
Vaughan, Canada
Inimmune
Harnessing the immune system to create next generation immunotherapeutics for the treatmen...
Missoula, United States
Locanabio, Inc.
Creating RNA-targeting gene therapies to treat devastating diseases
San Diego, United States
About Dicerna Pharmaceuticals
Dicerna Pharmaceuticals is a biotechnology firm pioneering breakthroughs in genetic disorders and liver diseases through RNA interference technology. The company, founded in 2007, is headquartered in Lexington, Massachusetts. Dicerna focuses on developing treatments for rare inherited liver diseases, cancers, and other...
RNA Interference, Genetic Disorders, Liver Diseases, Rare Diseases, Therapeutics, RNAi Technology, Pharmaceuticals, Drug Discovery, Inherited Liver Diseases, Cancer Treatment, Cardiovascular Disease, Hepatitis B, Orphan Genetic Diseases, Medical Research
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Dicerna Pharmaceuticals and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Dicerna Pharmaceuticals on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 23 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
